Bio-Rad Platelia Aspergillus EIA
Description:... in 3 hours. When used in conjunction with other diagnostic procedures, Platelia Aspergillus EIA is an aid in the diagnosis of Invasive aspergillosis in immunocompromised patients undergoing hematopoietic stem cell transplantation and in patients with hematological malignancy. Aspergillus ...Chronic obstructive pulmonary disease
... may cause secondary polycythemia ; ... One type of Immune Complex Initiated Hypersensitivity (Type III) reactions. Allergic Broncho pulmonary aspergillosis ( ABPA ), Chronic obstructive pulmonary disease and Farmer's lung are examples of an arthus reaction. Cigarette smoking was also found to be ...New text focuses on formidable opportunistic fungus
... William J. Steinbach of Duke University. Aspergillus fumigatus and aspergillosis assembles chapters from a large and international contingent of experts ... which agent to use. "It is our intent that Aspergillus fumigatus and aspergillosis will encompass the current state of knowledge to serve as a resource ...Gamma interferon could aid fight against fungal infections
... the mechanisms of these cells to make them more potent killers of fungi. Tests on many fungal infections, including blastomycosis, candidosis and aspergillosis have shown that gamma interferon has beneficial effects in terms of the reduction of the fungus in the organs and on animal survival. But according ...Pillows - a hot bed of fungal spores
... the pillows, is most likely to cause disease; and the resulting condition aspergillosis has become the leading infectious cause of death in leukaemia and bone ... plant pots, compost, computers and ground pepper and spices. Invasive aspergillosis occurs mainly in the lungs and sinuses, although it can spread to other ...Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
... (highest rating) for the prevention of invasive Aspergillus infections in certain high-risk patients in the latest Treatment of aspergillosis Clinical Practice Guidelines of the Infectious Diseases Society of America. (Announced Jan. 31, 2008) -- Gained FDA approval of ASMANEX ...